Question

What research stage is stem-cell therapy for Erectile Dysfunction at?

2 of 35 registered records carry a Phase 3 or Phase 4 label. The rest sit at earlier phases or carry no phase label at all. Snapshot 2026-08-29.

Medical review statusMedically reviewedReviewed by: Stem Plus medical teamReviewed on: 2026-08-29Last evidence update: 2026-08-29Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

Phase distribution

Phase labelRecordsShare
Phase 12248%
Phase 21533%
Not applicable715%
Phase 324%

What the phase mix means for Erectile Dysfunction

Most registrations are early-phase and small, with short follow-up. That is a poor fit for a condition where placebo response on questionnaire scores is large and well documented across decades of drug trials.

The later-phase studies themselves

StudyPhaseStatusPlanned nLead sponsorStart
NCT07480161 — Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile DysfunctionPhase 2, Phase 3Recruiting90Ankara City Hospital Bilkent2025-12-29
NCT04972890 — The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile DysfunctionPhase 2, Phase 3Unknown12Indonesia University2020-10-27

How to read phase labels

Early phases exist to find harm and set a dose. They are not built to detect benefit, and they routinely produce encouraging-looking numbers that later trials fail to reproduce. Only a confirmatory design with a comparison arm can separate the intervention from everything else happening to a patient.

Median planned enrolment across sampled studies here is 30 participants. Small single-arm studies can flag safety problems; they cannot separate a treatment effect from natural fluctuation, placebo response or regression to the mean.

The largest studies by planned enrolment

Size is a crude proxy for what a study can detect, but it separates a serious attempt from a case series presented as evidence.

StudyPhaseStatusPlanned nLead sponsorStart
NCT04684602 — Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute ConditionsPhase 1, Phase 2Recruiting5,000Thomas Advanced Medical LLC2020-07-09
NCT03899298 — Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical ConditionsPhase 1Not Yet Recruiting5,000R3 Stem Cell2019-09-01
NCT01953523 — Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditionsn/aCompleted3,000Elliot Lander2013-09-02
NCT07544537 — A Prospective Comparative Study of Autologous Bone Marrow-Derived and Adipose Tissue-Derived Mesenchymal Stem Cells Versus Platelet-Rich Plasma and StPhase 2Active Not Recruiting100National Scientific Medical Center, Kazakhstan2024-09-09
NCT07480161 — Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile DysfunctionPhase 2, Phase 3Recruiting90Ankara City Hospital Bilkent2025-12-29

Frequently asked

What research stage is stem-cell therapy for Erectile Dysfunction at?

2 of 35 records are labelled Phase 3 or 4 (2026-08-29).

Is a Phase 3 trial proof that it works?

No — it is a design capable of testing that question. Proof depends on the reported result, replication, and whether the outcome measured matters to patients.

Why do so many records have no phase?

Observational studies and some cell-therapy protocols are registered without a phase label. It is a registry field, not a quality rating.

Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.

Explore all sections · Data & downloads